About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Tailoring TM-HTN Intervention for Black Patients | Clinical Trials | Clareo Health

Back to clinical trial search

Not Yet RecruitingNANCT06593119

Tailoring TM-HTN Intervention for Black Patients

Current clinic-based hypertension (HTN) management models have several limitations, resulting in episodic care that does not adequately support patients' self-care skills, and fails to achieve blood p...

Lead sponsor: Wake Forest University Health Sciences•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Camelia Singletary, MPH

CONTACT

336.713.7210 crsingle@wakehealth.edu

Sponsors

Lead Sponsor

Wake Forest University Health Sciences

Telemedicine management of HTN (TM-HTN) can augment and overcome challenges by allowing more support for patients' HTN self-care skills, providing multiple home Blood Pressure values and overcoming failure to appropriately intensify treatment. TM-HTN consists of 1) home BP monitoring, 2) home BP based pharmacotherapy, and 3) telemedicine-based self-management support.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Subjects must be African American or Black
•experiencing socially disadvantage
•Patients with systolic Blood Pressure ≥140 mmHg on their last two clinic visits and baseline systolic BP \>130 mmHg using the mean of two research BP values measured by trained staff
•Subjects must be on stable Blood Pressure medications for the preceding 6 weeks

Exclusion Criteria

•Unable to read or speak English
•diminished ability to measure home Blood Pressure
•chronic kidney disease ≥stage 4
•persistent/chronic atrial fibrillation
•severe hypertension \>180/110 mmHg
•acute health changes in past 3 months increasing chance of Blood Pressure instability
•terminal illness

Related studies

RECRUITINGPhase 3

A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)

NCT07481981 · Pulmonary Arterial Hypertension

Mitigation of Health Effects in Older Adults With Hypertension by Reducing Exposure to Heat and Air Pollution

NCT07606859 · Hypertension Arterial, 65 Years Older

RECRUITINGPhase 4

Treatment With Aspirin After Preeclampsia: TAP Trial

NCT06281665 · Hypertensive Disorder of Pregnancy, Pre-Eclampsia, and more

Regional Innovation in Chronic Disease and Elderly Care

NCT07578090 · Hypertension, Cardiovascular Disease, and more

Microplastics, Cirrhosis and Portal Hypertension

NCT07280390 · Cirrhosis, Microplastics, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 28, 2025Terms

Trial snapshot

StatusNOT_YET_RECRUITING

PhaseNA

Enrollment60

Start dateAug 2026

Last updatedAug 28, 2025

Condition

Locations shown

Wake Forest University Health Sciences

Winston-Salem, North Carolina

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 28, 2025Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions